Advertisement

Gerontology pp 121-131 | Cite as

Drug Treatment of Hypertensive Geriatric Patients

  • R. D. Kennedy
Conference paper

Abstract

The management of hypertension in the elderly and old has remained controversial for over 30 years. It has been one of those areas where geriatricians have frequently found themselves in conflict with the attitudes of the general internist. Moreover, the success of national programs aimed at detecting and lowering blood pressure has had a major effect on both the profession’s and the public’s attitude to this problem, particularly in the United States.

Keywords

Glomerular Filtration Rate Lower Blood Pressure Systolic Hypertension Raise Blood Pressure White Coat Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alderman MH, Davis TK, Gerber LM (1985) Step-down therapy for hypertension. Results of a community based program. Postgrad Med 77 (7): 89–92, 96–99Google Scholar
  2. Amery A, Brixco P, Clement D (1985) Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet I: 1349–1354Google Scholar
  3. Anderson TW (1978) Re-examination of some of the Framingham blood pressure data. Lancet II: 1139–1141Google Scholar
  4. Applegate WB, Carper ER, Kahn SE, Westbrook L, Linton M, Barker MG, Runyan JW (1985) Comparison of the use of reserpine versus alpha-methyldopa for second step treatment of hypertension in the elderly. J Am Geriatr Soc 33: 109–115PubMedGoogle Scholar
  5. Asnouri OS (1986) Severe diuretic induced hyponatremia in the elderly. A series of eight patients. Arch Intern Med 146: 1355–1357CrossRefGoogle Scholar
  6. Brown J, Dollery C, Valdes G (1986) Interaction of nonsteroidal anti-inflammatory drugs with anti-hypertensive and diuretic agents: control of vascular reactivity by endogenous prostanoids. Am J Med 81 (Suppl 2B): 43–47PubMedCrossRefGoogle Scholar
  7. Croog SH, Levine S, Testa MA et al. (1986) The effects of anti-hypertensive therapy on the quality of life. N Engl J Med 314: 1657–1664PubMedCrossRefGoogle Scholar
  8. Cruickshank JM, Thorp JM, Zacharies FJ (1987) Benefits and potential harm of lowering high blood pressure. Lancet I: 581–584Google Scholar
  9. Heal RC, Brogden RN, Speight TM (1980) Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs 20: 409–452CrossRefGoogle Scholar
  10. Hulley SB, Feigal D, Ireland C, Kuller LH, Smith WM (1986) Systolic hypertension in the elderly program (SHEP). The first three months. J Am Geriatr Soc 34: 101–105Google Scholar
  11. Intersalt (1988) An international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. Br Med J 297: 319–328CrossRefGoogle Scholar
  12. Lawson DM, Jick H (1976) Drug prescribing in hospitals: a international comparison. Am J Public Health 66: 644–648PubMedCrossRefGoogle Scholar
  13. Lees KR, Reid JL (1987) Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment. Clin Pharmacol Ther 41: 597–602PubMedCrossRefGoogle Scholar
  14. Lynn KL, Bailey RR, Swainson CP, Sainsbury R, Low WI (1985) Renal failure with potassium sparing diuretics. NZ Med J 98: 629–633Google Scholar
  15. Meyer JS, Judd BW, Tawakina T, Rogers RL, Mostel KF (1986) Improved cognition after control of risk factors for multi-infarct dementia. JAMA 256: 2203–2209PubMedCrossRefGoogle Scholar
  16. Miller HW (1973) National Center for Health Statistics. Plan and operation of the national health and nutritional examination survey, United States 1971–73. Vital and health statistics, series 1 Nos. 10a, 10b, US Department of Health, Education and Welfare, Publications No. 73-1310, US Government Printing Office, pp 1–46Google Scholar
  17. Pickering G (1972) Hypertension and definitions: national histories and consequences. Am J Med 52: 570PubMedCrossRefGoogle Scholar
  18. Pickering TG, James GO, Boddie C, Harshfield GA, Blank S, Laragh JH (1988) How common is white coat hypertension? JAMA 259: 225–228PubMedCrossRefGoogle Scholar
  19. Rouse IL, Beilin LJ (1984) Vegetarian diet and blood pressure. J Hypertens 2: 231–240PubMedCrossRefGoogle Scholar
  20. Tuck ML, Griffiths RF, Johnson LE, Stern N, Morley JE (1988) UCLA grand rounds: hypertension in the elderly. J Am Geriatr Soc 36: 630–643PubMedGoogle Scholar
  21. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1967) Effects of treatment on morbidity in hypertension. JAMA 202: 1028–1034CrossRefGoogle Scholar
  22. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1970) Effects of treatment on morbidity in hypertension II. JAMA 213: 1143–1182CrossRefGoogle Scholar
  23. Ying CY, Tifft CP, Gavras H, Chobonian AV (1984) Renal revascularization in the azotemic hypertensive patient resistant to therapy. N Engl J Med 31: 1070–1075CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • R. D. Kennedy
    • 1
  1. 1.Geriatric Division, Montefiore Medical CenterAlbert Einstein College of MedicineNew YorkUSA

Personalised recommendations